NCT05383092Recruiting
Adapted Physical Activity for Children Treated With Cancer and Insulin Sensitivity
Source: ClinicalTrials.gov · Last updated 21 Sept 2023 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The main objective of this study is to evaluate the evolution of the sensitivity to insulin, a hormone that acts on sugar in the body, as well as other metabolic, motor and nutritional elements of children with cancer, according to the practice of intense physical activities or stretching. In view of the scientific work on this subject, it is expect to observe that the practice of intense physical activities will improve the results of the children in the metabolic, motor and nutritional evaluations, compared to the stretching program.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- First submitted
- 16 May 2022
- Start date
- 11 Jul 2022
- Primary completion date
- 31 Dec 2026
- Lead sponsor
- University Hospital, Toulouse
- Diseases
- Childhood cancers
- NCT number
- NCT05383092
What you commit to
- Study type: Interventional
- Planned participants: 60
- From 11 Jul 2022 to the primary completion date, 31 Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- have a pre-existing heart disease that is not suitable for adapted physical activities;
- have a known type 1 diabetes
Other
- present a physical and/or psychological impossibility to follow an adapted physical activity program;
- have an obesity defined by a body mass index greater than or equal to the International Obesity Task Force 25 threshold
Who the study is looking for
- age between 5 and 18 years old;
- have a solid cancer or hematological disease;
- be treated for the first time in pediatric oncology and hematology department;
- have an estimated life expectancy at diagnosis of more than 6 months.
Age in the registry: 5 years to 18 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| PASQUET Marlène Coordinator of this site? Confirm its status | Toulouse | France | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.